Long-term benefit of mTOR inhibitors for dropping calcineurin inhibitors in liver transplant recipients

被引：0
|
作者：
Milgrom, Yael [1 ]
Imam, Ashraf [1 ]
Jammal, Alaa [1 ]
Shabaneh, Suha [1 ]
Amer, Johnny [1 ]
Shafrir, Asher [1 ]
Massarwa, Muhammad [1 ]
Hazou, Wadi [1 ]
Khakayla, Abed [1 ]
Safadi, Rifaat [1 ]
机构：
[1] Hadassah Hebrew Univ Hosp, Liver Inst, Jerusalem, Israel
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-532
引用
收藏
页码：S484 / S485
页数：2
相关论文
共 50 条
  • [1] Long-Term Renal Function in Liver Transplant Recipients After Conversion From Calcineurin Inhibitors to mTOR Inhibitors
    Huesing, Anna
    Schmidt, Martina
    Cicinnati, Vito R.
    Koch, Raphael
    Thoelking, Gerold
    Stella, Jaqueline
    Heinzow, Hauke
    Schmidt, Hartmut H.
    Kabar, Iyad
    [J]. ANNALS OF TRANSPLANTATION, 2015, 20
  • [2] mTOR inhibitors in kidney transplant recipients: long-term efficacy and discontinuation causes
    Cassia, Matthias
    Cacho, Judit
    Vergara Perez, Hugo
    Torres Jaramillo, Maria Veronica
    Alberici, Federico
    Diekmann, Fritz
    Cucchiari, David
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I1625 - I1626
  • [3] Long-Term Redistribution of Peripheral Lymphocyte Subpopulations after Switching from Calcineurin to mTOR Inhibitors in Kidney Transplant Recipients
    Llinas-Mallol, Laura
    Redondo-Pachon, Dolores
    Raich-Regue, Dalia
    Perez-Saez, Maria Jose
    Yelamos, Jose
    Duran, Xavier
    Faura, Anna
    Lopez-Botet, Miguel
    Pascual, Julio
    Crespo, Marta
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)
  • [4] MTOR INHIBITORS IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS
    Dumortier, J.
    Couchonnal, E.
    Lacaille, F.
    Rivet, C.
    Debray, D.
    Boillot, O.
    Lachaux, A.
    Ackermann, O.
    Gonzales, E.
    Wildhaber, B. E.
    Jacquemin, E.
    Mc Lin, V.
    [J]. TRANSPLANT INTERNATIONAL, 2019, 32 : 17 - 17
  • [5] mTOR inhibitors in pediatric liver transplant recipients
    Dumortier, Jerome
    Couchonnal, Eduardo
    Lacaille, Florence
    Rivet, Christine
    Debray, Dominique
    Boillot, Olivier
    Lachaux, Alain
    Ackermann, Oanez
    Gonzales, Emmanuel
    Wildhaber, Barbara E.
    Jacquemin, Emmanuel
    McLin, Valerie
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2019, 43 (04) : 403 - 409
  • [6] Long-Term Glomerular Filtration Rate in Liver Allograft Recipients According to the Type of Calcineurin Inhibitors
    Niel, O. R. P.
    Berthoux, F.
    Albano, L.
    Dahan, P.
    Aoudia, R.
    Gugenheim, J.
    Cassuto, E.
    [J]. TRANSPLANTATION PROCEEDINGS, 2009, 41 (08) : 3329 - 3332
  • [7] THE SAFETY AND EFFICACY OF CONVERSION FROM CALCINEURIN INHIBITORS TO mTOR INHIBITORS IN STABLE KIDNEY TRANSPLANT RECIPIENTS
    Asanga, Abeyaratne
    Michael, Collins
    Kym, Bannister
    Graeme, Russ
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2012, 90 (08): : A1 - A1
  • [8] Changes in Immunophenotypes After Conversion from Calcineurin Inhibitors to mTOR Inhibitors in Renal Transplant Recipients
    Yildiz, A.
    Cavusoglu, M.
    Adin, S.
    Caliskan, Y.
    Ozkok, A.
    Tasci, H.
    Deniz, G.
    Sariyar, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [9] Safety and immunologic benefits of conversion to sirolimus in kidney transplant recipients with long-term exposure to calcineurin inhibitors
    Yu, Ji Hyun
    Kim, Kyoung Woon
    Kim, Bo-Mi
    Chung, Byung Ha
    Cho, Mi-La
    Choi, Bum Soon
    Park, Cheol Whee
    Kim, Yong-Soo
    Yang, Chul Woo
    [J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2016, 31 (03): : 552 - 559
  • [10] Conversion of calcineurin inhibitors to sirolimus in liver transplant recipients.
    Mies, Sergio
    Beduschi, Thiago
    Silva, Vinicius M. R.
    Mies, Ana Olga N. G. F.
    Della Guardia, Bianca
    Baia, Carlos E. S.
    de Almeida, Marcio D.
    [J]. LIVER TRANSPLANTATION, 2007, 13 (06) : S189 - S189
12345